Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
Add more filters











Publication year range
1.
Biol Trace Elem Res ; 180(2): 275-284, 2017 Dec.
Article in English | MEDLINE | ID: mdl-28389902

ABSTRACT

This study investigated the toxicity of rats exposed to lead acetate (AcPb) during the second phase of brain development (8-12 days postnatal) in hematological and cerebral parameters. Moreover, the preventive effect of zinc chloride (ZnCl2) and N-acetylcysteine (NAC) was investigated. Pups were injected subcutaneously with saline (0.9% NaCl solution), ZnCl2 (27 mg/kg/day), NAC (5 mg/kg/day) or ZnCl2 plus NAC for 5 days (3rd-7th postnatal days), and with saline (0.9% NaCl solution) or AcPb (7 mg/kg/day) in the five subsequent days (8th-12th postnatal days). Animals were sacrificed 21 days after the last AcPb exposure. Pups exposed to AcPb presented inhibition of blood porphobilinogen-synthase (PBG-synthase) activity without changes in hemoglobin content. ZnCl2 pre-exposure partially prevented PBG-synthase inhibition. Regarding neurotoxicity biomarkers, animals exposed to AcPb presented a decrease in cerebrum acetylcholinesterase (AChE) activity and an increase in Pb accumulation in blood and cerebrum. These changes were prevented by pre-treatment with ZnCl2, NAC, and ZnCl2 plus NAC. AcPb exposure caused no alteration in behavioral tasks. In short, results show that AcPb inhibited the activity of two important enzymatic biomarkers up to 21 days after the end of the exposure. Moreover, ZnCl2 and NAC prevented the alterations induced by AcPb.


Subject(s)
Acetylcysteine/therapeutic use , Cerebrum/drug effects , Chlorides/therapeutic use , Lead Poisoning, Nervous System/prevention & control , Neurons/drug effects , Neuroprotective Agents/therapeutic use , Zinc Compounds/therapeutic use , Acetylcholinesterase/metabolism , Acetylcysteine/administration & dosage , Animals , Animals, Newborn , Biomarkers/blood , Biomarkers/metabolism , Blood-Brain Barrier/drug effects , Blood-Brain Barrier/metabolism , Cerebrum/enzymology , Cerebrum/metabolism , Chlorides/administration & dosage , Chlorides/metabolism , Chlorides/pharmacokinetics , Drug Therapy, Combination , Environmental Pollutants/blood , Environmental Pollutants/metabolism , Environmental Pollutants/toxicity , GPI-Linked Proteins/antagonists & inhibitors , GPI-Linked Proteins/metabolism , Injections, Subcutaneous , Lead/blood , Lead/metabolism , Lead/toxicity , Lead Poisoning, Nervous System/blood , Lead Poisoning, Nervous System/metabolism , Nerve Tissue Proteins/antagonists & inhibitors , Nerve Tissue Proteins/metabolism , Neurons/enzymology , Neurons/metabolism , Neuroprotective Agents/administration & dosage , Neuroprotective Agents/metabolism , Neuroprotective Agents/pharmacokinetics , Organometallic Compounds/administration & dosage , Porphobilinogen Synthase/antagonists & inhibitors , Porphobilinogen Synthase/blood , Random Allocation , Rats, Wistar , Tissue Distribution/drug effects , Toxicokinetics , Zinc Compounds/administration & dosage , Zinc Compounds/metabolism , Zinc Compounds/pharmacokinetics
2.
Mem Inst Oswaldo Cruz ; 106(4): 385-9, 2011 Jun.
Article in English | MEDLINE | ID: mdl-21739023

ABSTRACT

In order to mark Triatoma brasiliensis, the vector of Chagas disease in Brazil, two chemical compounds, rubidium chloride (RbCl) and chromium chloride (CrCl3), were tested. First, 199 N2-N5 nymphs were fed on blood with 0.025M RbCl. Rb marker positivity ranged from 2.5% (N3)-70% (N2), with a maximum persistence of 98 days. Second, 265 N2-N5 nymphs were fed on blood containing 0.0015M CrCl3. Cr marker positivity ranged up to 93% (N5), with a maximum persistence of 119 days. Finally, we blood fed 213 T. brasiliensis to investigate whether CrCl3 altered the biology of this insect. The developmental time of T. brasiliensis was unaltered, but the survival of the Cr-marked group was lower than that of the control group. Differences in the mean fecundity of the control (mean of 156.1) and experimental (mean of 135.6) groups were not statistically significant and 100% of the egg batches of females Cr-marked as nymphs were positive. In conclusion, CrCl3 is a useful tool for marking T. brasiliensis nymphs due to its high positivity and persistence.


Subject(s)
Chlorides/pharmacokinetics , Chromium Compounds/pharmacokinetics , Coloring Agents/pharmacokinetics , Insect Vectors/physiology , Nymph/physiology , Rubidium/pharmacokinetics , Triatoma/physiology , Animals , Chagas Disease/transmission , Female , Fertility/drug effects , Fertility/physiology , Insect Vectors/drug effects , Nymph/drug effects , Time Factors , Triatoma/drug effects
3.
Mem. Inst. Oswaldo Cruz ; 106(4): 385-389, June 2011. mapas, tab
Article in English | LILACS | ID: lil-592178

ABSTRACT

In order to mark Triatoma brasiliensis, the vector of Chagas disease in Brazil, two chemical compounds, rubidium chloride (RbCl) and chromium chloride (CrCl3), were tested. First, 199 N2-N5 nymphs were fed on blood with 0.025M RbCl. Rb marker positivity ranged from 2.5 percent (N3)-70 percent (N2), with a maximum persistence of 98 days. Second, 265 N2-N5 nymphs were fed on blood containing 0.0015M CrCl3. Cr marker positivity ranged up to 93 percent (N5), with a maximum persistence of 119 days. Finally, we blood fed 213 T. brasiliensis to investigate whether CrCl3 altered the biology of this insect. The developmental time of T. brasiliensis was unaltered, but the survival of the Cr-marked group was lower than that of the control group. Differences in the mean fecundity of the control (mean of 156.1) and experimental (mean of 135.6) groups were not statistically significant and 100 percent of the egg batches of females Cr-marked as nymphs were positive. In conclusion, CrCl3 is a useful tool for marking T. brasiliensis nymphs due to its high positivity and persistence.


Subject(s)
Animals , Female , Chlorides/pharmacokinetics , Chromium Compounds/pharmacokinetics , Coloring Agents/pharmacokinetics , Insect Vectors/physiology , Nymph/physiology , Rubidium/pharmacokinetics , Triatoma/physiology , Chagas Disease/transmission , Fertility , Fertility/physiology , Insect Vectors , Nymph , Time Factors , Triatoma
4.
Life Sci ; 81(16): 1264-71, 2007 Sep 29.
Article in English | MEDLINE | ID: mdl-17916369

ABSTRACT

Several studies have described mercury toxicity and the role of metallothioneins (MT) in the detoxification and regulation of metal homeostasis. However, little data exist on this topic during the specific post-natal developmental phase in young mammals. This developmental phase is particularly important since young animals are more sensitive to toxicants than adults. The objective of this work was to investigate whether MT participates in the mechanism of protection conferred by zinc pre-treatment on the toxic effects induced by mercury in neonate rats. Pups were exposed to ZnCl(2) (5 doses of 27 mg/kg/day, s.c.) and subsequently to HgCl(2) (5 doses of 5 mg/kg/day, s.c.); metal (Zn and Hg) and MT contents were analyzed in the liver, kidney, and blood. MT was induced in the liver and kidney of pups of both Zn-sal and Zn-Hg groups, although the greatest increase was in neonates exposed to Zn only. A direct relationship exists between MT and metals for both hepatic and renal tissues, which indicates that the increase in metal levels occurs in parallel to the increase in MT content. Although the heat-treated cytosolic fraction is rich in MT and metals, higher Zn and Hg contents were detected in the insoluble fraction of all tissues. These results suggest that MT is, at least in part, responsible for preventing Hg accumulation in the liver and blood and decreasing renal toxicity.


Subject(s)
Chlorides/pharmacology , Kidney/drug effects , Liver/drug effects , Mercuric Chloride/toxicity , Mercury Poisoning, Nervous System , Metallothionein/biosynthesis , Zinc Compounds/pharmacology , Animals , Animals, Newborn , Chlorides/blood , Chlorides/pharmacokinetics , Chlorides/therapeutic use , Female , Kidney/growth & development , Kidney/metabolism , Liver/growth & development , Liver/metabolism , Male , Mercuric Chloride/blood , Mercuric Chloride/pharmacokinetics , Mercury Poisoning, Nervous System/etiology , Mercury Poisoning, Nervous System/metabolism , Mercury Poisoning, Nervous System/prevention & control , Rats , Rats, Wistar , Zinc Compounds/blood , Zinc Compounds/pharmacokinetics , Zinc Compounds/therapeutic use
5.
J Am Soc Nephrol ; 14(2): 271-82, 2003 Feb.
Article in English | MEDLINE | ID: mdl-12538726

ABSTRACT

The rat thiazide-sensitive Na-Cl cotransporter (rNCC) is expressed in the renal distal convoluted tubule and is the site of action of an important class of antihypertensive agents, the thiazide diuretics. The amino acid sequence contains two potential N-linked glycosylation consensus sites, N404 and N424. Either enzymatic deglycosylation or tunicamycin reduced the cotransporter to its core molecular weight (113 kD). Glycosylation site single mutants expressed in oocytes ran as thick bands at 115 kD, consistent with the high-mannose glycoprotein. The double mutant produced the single thin 113-kD band seen in the deglycosylated cotransporter. Functional expression of cotransporters in Xenopus laevis oocytes revealed that the mutants displayed drastically decreased thiazide-sensitive (22)Na(+) uptake compared with wild-type NCC. Analysis of enhanced green fluorescence protein (EGFP)-tagged cotransporters demonstrated that this decrease in function is predominantly secondary to decreased surface expression. The elimination of glycosylation in the double mutant increased thiazide sensitivity by more than two orders of magnitude and also increased Cl(-) affinity. Thus, we have demonstrated that rNCC is N-glycosylated in vivo at two sites, that glycosylation is essential for efficient function and surface expression of the cotransporter, and that the elimination of glycosylation allows much greater access of thiazide diuretics to their binding site.


Subject(s)
Carrier Proteins/metabolism , Receptors, Drug/metabolism , Symporters , Thiadiazines/metabolism , Animals , Binding, Competitive , Carrier Proteins/genetics , Cell Membrane/metabolism , Chlorides/pharmacokinetics , Female , Glycosylation , Male , Mutation , Rats , Rats, Sprague-Dawley , Receptors, Drug/genetics , Sodium/pharmacokinetics , Sodium Chloride Symporters , Solute Carrier Family 12, Member 3 , Xenopus laevis
6.
Neurosci Lett ; 328(2): 170-4, 2002 Aug 09.
Article in English | MEDLINE | ID: mdl-12133581

ABSTRACT

Chronic exposure to manganese (Mn) positively correlates with the occurrence of Parkinsonism but little is known about mechanisms of its neurotoxicity. In the present study, we determined the clearance of Mn from rat substantia nigra after its nigral injection and correlated it with the establishment of apomorphine-induced rotational behaviour and loss of striatal tyrosine hydroxylase (TH) immunoreactivity. Our results suggest that Mn is slowly cleared from the substantia nigra, following a first-order kinetics with a t(1/2) of 3 days. Appearance of apomorphine-induced rotational behaviour and loss of TH immunoreactivity within the striatum follows metal clearance were both detected 24 hours after intra-nigral Mn microinjection and maximal 72 hours after injection. The present data suggest that the cellular mechanisms induced by Mn and leading to dopaminergic cell death, occurred shortly after its injection and that the metal concentration needs to reach a threshold value to induce neurotoxic effects. This would indicate that nigral damages are a direct consequence of Mn accumulation.


Subject(s)
Manganese Poisoning/metabolism , Manganese/pharmacokinetics , Neurons/drug effects , Parkinsonian Disorders/chemically induced , Parkinsonian Disorders/metabolism , Substantia Nigra/drug effects , Animals , Apomorphine/pharmacology , Cell Death/drug effects , Cell Death/physiology , Chlorides/pharmacokinetics , Chlorides/toxicity , Dopamine/metabolism , Dopamine Agonists/pharmacology , Gliosis/chemically induced , Gliosis/metabolism , Gliosis/physiopathology , Immunohistochemistry , Male , Manganese Compounds/pharmacokinetics , Manganese Poisoning/physiopathology , Metabolic Clearance Rate/drug effects , Metabolic Clearance Rate/physiology , Microinjections , Neurons/metabolism , Parkinsonian Disorders/physiopathology , Rats , Rats, Inbred Strains , Rotation , Substantia Nigra/metabolism , Substantia Nigra/physiopathology , Tyrosine 3-Monooxygenase/metabolism
7.
Brain Res Bull ; 46(3): 237-44, 1998 Jun.
Article in English | MEDLINE | ID: mdl-9667818

ABSTRACT

Adult female rats, undernourished at perinatal age, were evaluated for anxiolytic action in the plus-maze test after acute and chronic administration of diazepam (DZP) and pentobarbital (PTB). Deprived (D) rats chronically treated with vehicle showed an increased anxiety as compared with control (C) animals. A single intraperitoneal (i.p.) administration of DZP (1 mg/kg) or PTB (7.5 mg/kg) produced similar anticonflict effect in both C and D rats. Tolerance to the anxiolytic effect of DZP and PBT developed in C rats after a 15-day administration schedule, whereas no tolerance was observed in D animals. Drug disposition was not altered after chronic treatment either in C or in D rats. Gamma-aminobutyric acid (GABA)-mediated chloride uptake in microsacs of cerebral cortex of naive D rats was decreased as compared with naive C rats. After chronic DZP administration (1 mg/kg/day i.p. for 15 days), GABA-mediated 36Cl- influx in brain cortex microsacs of C rats did not change; however, GABA efficacy was increased in microsacs of D animals. In addition, chronic DZP treatment induced GABA-benzodiazepine uncoupling in brain cortex of C rats, but not in D animals, as assessed by chloride uptake in microsacs. Chronic PTB treatment (7.5 or 30 mg/kg/day i.p. for 15 days) did not modify GABA stimulation or GABA-PTB interaction in cortical microsacs of C or D rats.


Subject(s)
Animals, Newborn/physiology , Anti-Anxiety Agents/administration & dosage , Diazepam/administration & dosage , Nutrition Disorders/physiopathology , Pentobarbital/administration & dosage , Animal Nutritional Physiological Phenomena , Animals , Anti-Anxiety Agents/pharmacokinetics , Anti-Anxiety Agents/pharmacology , Brain/metabolism , Chlorides/pharmacokinetics , Diazepam/pharmacokinetics , Diazepam/pharmacology , Drug Synergism , Drug Tolerance/physiology , Female , Maze Learning/drug effects , Pentobarbital/pharmacokinetics , Pentobarbital/pharmacology , Rats , Rats, Wistar , Time Factors , gamma-Aminobutyric Acid/pharmacology
8.
Int J Dev Neurosci ; 16(6): 469-75, 1998 Oct.
Article in English | MEDLINE | ID: mdl-9881295

ABSTRACT

In the present report we studied the GABA-stimulated 36Cl- uptake during chick optic lobe development in order to establish the ontogenetic profile of the functional GABAA receptor complex. A concentration-dependent stimulation of 36Cl- influx by GABA was demonstrated, starting at developmental stages as early as 10 days of incubation. The maximal GABA-induced 36Cl- uptake changed significantly during ontogeny with highest values near hatching. However, GABA potency to stimulate ion influx remained unchanged. We also examined the effect of two neurosteroids, allopregnanolone and epipregnanolone, on GABA-stimulated 36Cl- influx at three developmental stages (embryonic day 14, post-hatching day 1 and adult stage). Both steroids enhanced ion uptake in a concentration-dependent manner, exerting greater stimulatory effects at early developmental stages. Allopregnanolone displayed EC50 values lower than epipregnanolone at all three time points and was also more potent at post-hatching stages. Analysis of the GABA concentration-effect curve disclosed that both steroid decreased EC50 values for GABA stimulation while Emax levels were unaffected. In conclusion, our results showed an early appearance of the GABA-associated chloride channel together with the ability of neurosteroids to modulate GABA-gating of such channel.


Subject(s)
Chlorides/pharmacokinetics , GABA Modulators/pharmacology , Optic Lobe, Nonmammalian/embryology , Optic Lobe, Nonmammalian/metabolism , Pregnanolone/pharmacology , gamma-Aminobutyric Acid/pharmacology , Animals , Biological Transport/drug effects , Brain Chemistry/drug effects , Chick Embryo , Chloride Channels/physiology , Optic Lobe, Nonmammalian/chemistry , Receptors, GABA-A/physiology
9.
Eur J Pharmacol ; 330(2-3): 101-8, 1997 Jul 09.
Article in English | MEDLINE | ID: mdl-9253941

ABSTRACT

Rats chronically treated with diazepam (2 mg/kg per day, i.p.) for 21 days were tested 96 h after the last injection in both the forced swim test (inescapable stress) and in an active avoidance test (escapable stress). The influence of carbamazepine (7.5 mg/kg, i.p.) administered 25 min prior to each behavioral task was investigated. Withdrawn animals showed a reduced time spent in immobility in the forced swim test and an enhanced latency to escape in the active avoidance test. Both behavioral effects were normalized by a single carbamazepine administration. An additional experiment was performed to investigate the effect of a forced swim experience on cortical chloride uptake following GABA (gamma-aminobutyric acid) stimulation 96 h after diazepam withdrawal, and the influence of a single administration of carbamazepine on these effects. An increased chloride uptake was observed in vehicle-treated rats but not in diazepam-withdrawn animals following the swimming experience. Carbamazepine pretreatment enhanced chloride uptake after diazepam withdrawal but did not modify chloride flux in stressed or unstressed vehicle-treated rats. These results support the hypothesis that diazepam withdrawal affects the ability to develop adaptive responses to stress and that carbamazepine can normalize such an alteration.


Subject(s)
Analgesics, Non-Narcotic/pharmacology , Anti-Anxiety Agents/adverse effects , Behavior, Animal/drug effects , Carbamazepine/pharmacology , Diazepam/adverse effects , Stress, Physiological/drug therapy , Substance Withdrawal Syndrome/drug therapy , Animals , Avoidance Learning/drug effects , Cerebral Cortex/drug effects , Cerebral Cortex/metabolism , Chlorides/pharmacokinetics , Male , Rats , Rats, Wistar , Receptors, GABA-A/physiology , Stimulation, Chemical , Stress, Physiological/etiology , Substance Withdrawal Syndrome/etiology , Swimming , Time Factors , gamma-Aminobutyric Acid/pharmacology
10.
Article in Portuguese | MEDLINE | ID: mdl-1340017

ABSTRACT

In the conducting airway, the epithelial electrolyte transport processes play an important role in determining the composition of the respiratory tract fluid. Apical membrane Cl- and Na+ channels control the secretion and absorption of epithelial cells. Defective regulation of these channels is a prominent characteristic of cystic fibrosis.


Subject(s)
Chlorides/pharmacokinetics , Cystic Fibrosis/metabolism , Lung/metabolism , Sodium/pharmacokinetics , Biological Transport, Active , Epithelium/metabolism , Epithelium/pathology
11.
Arch Biol Med Exp ; 23(4): 277-84, 1990 Dec.
Article in Spanish | MEDLINE | ID: mdl-1724894

ABSTRACT

Cystic Fibrosis (CF) is the most common lethal genetic autosomic disease in Caucasians. The disease expresses itself in airway and other epithelial cells as a defective chloride ion absorption and secretion. At least, an abnormal cAMP-dependent regulation of an apically located chloride channel has been proposed as the underlying molecular defect. The gene responsible for CF has been identified and predicted to encode a membrane protein termed cystic fibrosis transmembrane conductance regulator (CFTR). The functional role of the predicted protein remains unclear, although strong evidence suggest that it is directly or indirectly involved in regulation of the apical chloride permeability in epithelial cells. This review discusses the fundamental issues currently being investigated in CF.


Subject(s)
Bucladesine/metabolism , Chlorides/pharmacokinetics , Cystic Fibrosis/physiopathology , Membrane Proteins/physiology , Cell Membrane Permeability , Chloride Channels , Cystic Fibrosis/genetics , Cystic Fibrosis/therapy , Cystic Fibrosis Transmembrane Conductance Regulator , Electrochemistry , Genetic Therapy , Humans , Membrane Proteins/genetics , Membrane Proteins/metabolism , Protein Kinase C/metabolism , Protein Kinases/metabolism , Transfection
14.
J Pediatr ; 115(3): 397-404, 1989 Sep.
Article in English | MEDLINE | ID: mdl-2671327

ABSTRACT

Some children with Bartter syndrome have hypercalciuria. To determine the mechanism for this phenomenon, we studied tubular function and calcium metabolism in six such children. All patients had hypokalemic alkalosis, normotension, hyperreninemia, growth retardation, low fractional distal chloride reabsorption (4/5), and elevated urinary prostaglandin E2 excretion (5/6). In addition, all had hypercalciuria (urinary calcium 6.5 to 25.0 mg/kg/day), with evidence of nephrocalcinosis in five. None, however, had evidence of rickets or hyperparathyroidism. There was a marked elevation in the serum concentration of 1,25-dihydroxyvitamin D in all, and four patients had a response to oral calcium loading suggestive of absorptive hypercalciuria. Five children have had long-term therapy with indomethacin. They have had improvement in hypokalemia and reduced urinary prostaglandin E2 excretion as well as reductions in the serum concentration of 1,25-dihydroxyvitamin D and in urinary calcium excretion. These data suggest that hypercalciuria in some children with Bartter syndrome is associated with an excess of 1,25-dihydroxyvitamin D. The improvement in hypercalciuria with prostaglandin synthesis inhibition may result in part from correction of this vitamin D abnormality.


Subject(s)
Bartter Syndrome/complications , Calcium Metabolism Disorders/etiology , Hyperaldosteronism/complications , Vitamin D/metabolism , Calcium Metabolism Disorders/physiopathology , Child, Preschool , Chlorides/pharmacokinetics , Dinoprostone/metabolism , Humans , Hyperaldosteronism/epidemiology , Indomethacin/therapeutic use , Infant , Kidney Tubules/physiopathology , Male , Potassium/pharmacokinetics , Renin/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL